1 week ago
SynbioTech to Showcase TWK10® in GLP-1 Nutrition Market
SynbioTech makes products that use probiotics and other microbiome technologies.
It will show one product, called TWK10®, at a nutrition trade show in Bangkok.
The company says new weight-management medicines are making brands think about more than just eating less.
They are also considering protein, muscles, movement and healthy aging.
Two studies described by the company tested TWK10® in different groups of people.
One study combined it with pea protein and exercise.
Another studied frail older adults for 18 weeks.
The studies reported improvements in some measures of amino acids, strength and movement.
These results are research findings, and SynbioTech is presenting them to companies developing nutrition products.
SynbioTech will present TWK10® and its microbiome CDMO platform at Vitafoods Asia 2026 in Bangkok from September 2–4.
The company is positioning TWK10® for companion nutrition products focused on protein utilization, muscle support, gut health and healthy aging.
A 28-day study combining pea protein and resistance training reported increases in amino-acid measures and improvements in several physical-performance outcomes.
An 18-week trial in frail older adults reported gains in grip strength, relative muscle mass, chair-stand performance and walking-balance measures.
SynbioTech says TWK10® has 27 scientific publications, nine human clinical studies, 18 global patents and regulatory milestones in several markets.
- Who
- SynbioTech, a Taiwan-based biotechnology company, and brands developing nutrition products.
- What
- SynbioTech will present Lactiplantibacillus plantarum TWK10® and its microbiome-focused contract development and manufacturing organization platform.
- Where
- Vitafoods Asia 2026 at the Queen Sirikit National Convention Center in Bangkok, Thailand; SynbioTech will exhibit at Booth H7-N32B.
- When
- September 2–4, 2026.
- Why
- The company aims to address growing interest in nutrition products accompanying GLP-1-based weight-management therapies, particularly products related to protein utilization, muscle support and healthy aging.
Key facts
- Company
- SynbioTech, founded in Taiwan in 2000, specializes in probiotics, postbiotics and microbiome-based health solutions.
- Featured ingredient
- Lactiplantibacillus plantarum TWK10®.
- Research record
- 27 scientific publications and nine human clinical studies, according to SynbioTech.
- Clinical finding
- In an 18-week trial involving frail older adults, the high-dose group recorded a 51% improvement in 30-second Chair Stand performance from baseline.
- Regulatory milestones
- SynbioTech cites a Taiwan anti-fatigue health claim, self-affirmed GRAS status in the United States, recognition in Korea, acceptance under Japan’s Foods with Function Claims system and Malaysia registration.
- Thailand status
- TWK10® was added to Thailand’s approved edible microbial strain list in 2024.
- CDMO services
- The platform covers strain selection, formulation development, clinical-study design, manufacturing and regulatory-documentation support.
Quotes
Sean Yang
Chief Operating Officer of SynbioTech
“GLP-1 has broadened weight management conversation beyond appetite control, i.e., eating less is no longer treated as being better nourished. For formulators, the opportunity is to design products that support how consumers use available nutrition while also thinking about strength, mobility and healthy aging. TWK10® provides a gut-muscle axis research foundation for this emerging companion-nutrition category.”
theprint.in
“Regulatory readiness is often where ingredient conversations slow down. For Thai and Southeast Asian brands, having a clinically studied strain with an established market-entry record can help shorten the path from concept to market. In a category evolving as quickly as GLP-1 companion nutrition, timing matters.”
theprint.in
Sources
Related news
Lord's Mark Industries Gets Licence for Gut Microbiome Analytics Platform
Nestle targets weight-loss drug users with AI-driven new products
Lord's Mark Industries Gets India's First Gut Microbiome Analytics License
Lupin Reassesses GLP-1 Market as It Develops New Treatments
World of Microbiome 2026 Highlights Precision Health In Bengaluru
Yoga Bar Launches Whey Isolate With Fermented Yeast Protein
Thai School Reopens Under Tight Security After Deadly Shooting
Bangkok Bar Shaves Woman’s Head Over Unpaid $1,800 Bill
Mumbai Customs Arrests Man Over 12.7-Kg Cannabis Seizure
Mumbai Customs Arrest Two Women Over Alleged Cannabis Smuggling
DRI Mumbai Busts Gold Smuggling Syndicate, Seizes ₹10.75 Crore
